Predictors of failure to detect early hepatocellular carcinoma in patients with chronic hepatitis B who received regular surveillance

ConclusionsIn CHB patients undergoing regular surveillance with ultrasonography and alpha‐foetoprotein (AFP) analysis every 6 months, the HCC detection failure rate was not high (0.8% per person; 0.1% per test). However, careful attention should be paid in patients with advanced liver fibrosis (clinical cirrhosis or LS value >11.7 kPa), high AFP levels, or diabetes mellitus, who are prone to surveillance failure.

Source: Alimentary Pharmacology and Therapeutics - March 1, 2018 Category: Drugs & Pharmacology Authors: Y. E. Chon, K. S. Jung, M. ‐J. Kim, J.‐Y. Choi, C. An, J. Y. Park, S. H. Ahn, B. K. Kim, S. U. Kim, H. Park, S. K. Hwang, K. S. Rim, K.‐H. Han, D. Y. Kim Tags: ORIGINAL ARTICLE Source Type: research